Making sense of genetic associations with childhood leukaemia risk
Making sense of genetic associations with childhood leukaemia risk
Childhood Cancer 2016: Conference review
Antibody-based and bispecific T-cell dependent therapies
NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls
Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project
Environmental exposure and childhood leukaemia
The CAR T cell revolution in cancer therapy
Development of a novel CD19 CAR with improved functionality
Immune strategies for treating neuroblastoma
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL
The timeline of adjuvant and neoadjuvant therapy for melanoma